Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-039917
Filing Date
2021-06-11
Accepted
2021-06-11 17:07:58
Documents
1
Period of Report
2021-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9597
  Complete submission text file 0001209191-21-039917.txt   10937
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE, SUITE 950 NASHVILLE TN 37203
Business Address
Bonner Michael (Reporting) CIK: 0001666790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 211012186